Viteva  Home logo
Supplement Safety

 Untitled 1
Pycnogenol Research

PYCNOGENOL in chronic venous insufficiency.

PYCNOGENOL chewing gum minimizes gingival bleeding and plaque formation.

Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile.

Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients.

Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II.

Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol.

Pycnogenol as an adjunct in the management of childhood asthma.

Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol.

Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol).

Treatment of ADHD with French maritime pine bark extract, Pycnogenol.

Cramps and muscular pain: prevention with pycnogenol in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy.

Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder.

Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study.

Rapid relief of signs/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study.

A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.

Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans.

Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis.

An examination of the effects of the antioxidant Pycnogenol on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population.

Pycnogenol may alleviate adverse effects in oncologic treatment.

Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol.

Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation.

 Untitled 1
   Home    Terms of Use    Privacy
Home    Research    Terms of Use    Privacy Policy    Advertise    Newsletter    About Us    Contact Us
Copyright ©2009 Viteva